Chronic treatment with the selective adenosine A(3) receptor agonist N
-6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA) administer
ed prior to either 10 or 20 min forebrain ischemia in gerbils resulted
in improved postischemic cerebral blood circulation, survival, and ne
uronal preservation. Opposite effects, i.e., impaired postischemic blo
od flow, enhanced mortality, and extensive neuronal destruction in the
hippocampus were seen when IB-MECA was given acutely. Neither adenosi
ne A(1) nor A(2) receptors are involved in these actions. The data ind
icate that stimulation of adenosine A(3) receptors may play an importa
nt role in the development of ischemic damage, and that adenosine A(3)
receptors may offer a new target for therapeutic interventions.